LGM Pharma Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
152
- Latest Deal Type
-
Fund - Cont Trans
- Financing Rounds
-
5
- Investments
-
4
LGM Pharma General Information
Description
Operator of a contract development and manufacturing organization (CDMO) intended for pharmaceutical and biotech markets. The company specializes in designing and manufacturing products to streamline the active pharmaceutical ingredient supply chain throughout various development stages while providing complete technical capabilities and expert regulatory support, enabling its clients to develop their custom-made processes and scale them efficiently.
Contact Information
Website
www.lgmpharma.comCorporate Office
- 6400 Congress Avenue
- Suite 1400
- Boca Raton, FL 33487
- United States
Corporate Office
- 6400 Congress Avenue
- Suite 1400
- Boca Raton, FL 33487
- United States
LGM Pharma Timeline
LGM Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LGM Pharma Comparisons
Industry
Financing
Details
LGM Pharma Competitors (9)
One of LGM Pharma’s 9 competitors is Dalton Pharma Services, a Corporate Backed or Acquired company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
| Biosynth | Private Equity-Backed | Berkshire, United Kingdom | ||||
| SST Corporation | Private Debt Financed | Fairfield, NJ | ||||
| Medichem Spain | Corporation | Sant Joan Despí, Spain | ||||
| IMCoPharma | Private Equity-Backed | Bilovec, Czech Republic |
LGM Pharma Signals
LGM Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LGM Pharma Investments (4)
LGM Pharma’s most recent deal was a Buyout/LBO with Sannova Analytical. The deal was made on 22-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sannova Analytical | 22-Oct-2026 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| Nexgen Pharma (Pharmaceutical Development and Manufacturing Unit) | 27-Jul-2020 | Buyout/LBO | Other Healthcare Services | ||
| Zeta Pharmaceuticals (Compounding Business) | 16-Mar-2018 | Buyout/LBO | Drug Delivery | ||
| Stereokem | 19-Jul-2013 | Corporate | Other Pharmaceuticals and Biotechnology |
LGM Pharma Exits (1)
LGM Pharma’s most recent exit was on 19-Jul-2013 from Stereokem. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Stereokem | 19-Jul-2013 | Completed |
|
LGM Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sannova Analytical | Somerset, NJ | 2006 |
LGM Pharma FAQs
-
When was LGM Pharma founded?
LGM Pharma was founded in 2005.
-
Where is LGM Pharma headquartered?
LGM Pharma is headquartered in Boca Raton, FL.
-
What is the size of LGM Pharma?
LGM Pharma has 152 total employees.
-
What industry is LGM Pharma in?
LGM Pharma’s primary industry is BPO/Outsource Services.
-
Is LGM Pharma a private or public company?
LGM Pharma is a Private company.
-
What is LGM Pharma’s current revenue?
The current revenue for LGM Pharma is .
-
How much funding has LGM Pharma raised over time?
LGM Pharma has raised $18.8M.
-
Who are LGM Pharma’s investors?
Capital Southwest and New Harbor Capital have invested in LGM Pharma.
-
Who are LGM Pharma’s competitors?
Dalton Pharma Services, Biosynth, SST Corporation, Medichem Spain, and IMCoPharma are some of the 9 competitors of LGM Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process